申请人:Crinetics Pharmaceuticals, Inc.
公开号:US20210238164A1
公开(公告)日:2021-08-05
Described herein are compounds that are melanocortin subtype-2 receptor (MC2R) modulators, methods of making such compounds, pharmaceutical compositions and medicaments comprising such compounds, and methods of using such compounds in the treatment of conditions, diseases, or disorders that would benefit from modulation of MC2R activity.